Fluorimetric determination of monosubstituted guanidino compounds with benzoin—dimethylformamide reagent

RGD nanodomains grafting onto titanium surface

Titanium alloys exhibit excellent biocompatibility and corrosion resistance in the body fluid and possess mechanical properties similar of the bones' properties. When the loss of osseous is important in osseous surgery, large biomaterials are implanted and should be accepted by the organism. For increasing the biomaterials biocompatibility, biological compounds can be linked or deposited on the material surface making them biologically active. In order to study the tissue-implant interaction and to favor osteoblast-adhesion onto titanium, our work deals with the grafting of cell-binding peptides containing the Arginine-Glycine-Aspartic acid (RGD) sequence. In the present study, we focus on the elaboration of patterned biomaterial surfaces with highly functionalized nanodomains. The strategy of RGD peptide immobilization involves first the grafting if an amino-functional organosilane (APTES). Then, each of the free amino moieties were used as an initiator core for a dendrimer-like synthesis to multiply the number of free groups available for RGD immobilization on the material surface.

Anisoin: A useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds

The use of anisoin as pre-chromatographic reagent for LC analysis of guanidino compounds is proposed. The reagent reacts (5 min at 100 degrees C) with guanidino function and the resulting adducts can be chromatographed under reversed-phase conditions. A fluorescence detector (lambda(ex)=325 nm; lambda(em)=435 nm) was used to detect guanidino adducts. The derivatization and chromatographic conditions were optimised by a series of experiments. Application to the determination of arginine and creatine in pharmaceuticals and arginine, guanidine, methylguanidine, guanidinosuccinic acid, beta-guanidinopropionic acid, gamma-guanidinobutyric acid, guanidinoacetic acid and homoarginine in human urine is described. Quantitation limits ranged from 6 to 30 fmol, except for creatine (510 fmol).

Fluorogenic reactions for biomedical chromatography

A number of fluorogenic reactions, which have been used for HPLC detection systems by means of pre- and/or postcolumn derivatization, are surveyed with respect to both sensitivity and selectivity for the determination of biomedically important substances. For the derivatization of the substances, two types of fluorogenic reactions, fluorescence-generating and fluorescence-tagging, have been studied. The former are usable in most instances for both pre- and postcolumn derivatization methods, and the latter only for precolumn derivatization methods. HPLC methods utilizing the fluorogenic reactions allow analytes to be detected at picomole-subfemtomole levels. In the fluorescence-generating reactions, several fluorogenic reagents possessing two or more reactive sites in the molecule, which show molecular recognition for a variety of analytes, permit facile and reproducible detection in HPLC because there are fewer interferences from biological matrices.

Chromatography and electrophoresis of creatinine and other guanidino compounds

Chromatographic methods, in general, are considered as the definitive and reference procedure. The HPLC procedures reviewed all seem to provide improved and adequate specificity and sensitivity for CRN assay. The HPLC methods are relatively easy to use, have nearly complete recoveries (greater than or equal to 95%) and have good precision. The within- and between-day variations are often less than 4% [85,87,90,94-97,99]. Most of the methods developed [84,85,90,91,94,97,99] were tested for potential interference and the specificity for CRN was demonstrated. One important advantage of the HPLC method [85] is that the presence of an interfering substance in the biological sample can most likely be detected by its influence on the sharpness and resolution of the CRN peak. It is understandable that there are possibilities that other constituents in the biological sample may also be co-eluting with CRN and the investigator should carefully examine the chromatogram obtained for any sign of interference. Ginman and Colliss [107] reported that azathioprine, cyclosporin A, cefotaxime and prednisolone used in patients after renal transplant interfered with the HPLC assay: the results are 40% higher than those by Jaffe method. These interferences, however, were corrected with a slight modification of the HPLC conditions [107]. Because of the non-specificity associated with the Jaffe reaction, the results obtained from Jaffe-based assays often exceed those from HPLC methods [95,108,109]. Such overestimation would be especially significant when the serum CRN is in the normal range where small changes may be indicative of a significant change in a patient's renal function [95,111]. It appears that HPLC methods are the methods of choice for simultaneous analysis of endogenous guanidino compounds. Depending on the purpose of analysis, one would choose a particular type of method, e.g., one among those representative methods listed in Table 1. If one is interested in measuring MG and GSA levels in serum or plasma, then depending on the sensitivity requirement and available instrumentations, one could choose many method listed in Table 1. However, if one needs to measure AARG, ARG and ARA, in addition to MG and GSA, then method 4 in Table 1 would be more appropriate. If TAU is the compound of interest, then one of the methods 2,3,4,5, and 7 with an appropriate deproteinization procedure would be desirable.

High-performance liquid chromatographic method for monitoring leupeptin in mouse serum and muscle by pre-column fluorescence derivatization with benzoin

A high-performance liquid chromatographic method is described for the determination of leupeptin, a possible therapeutic drug for muscular dystrophy, in mouse serum and muscle. Leupeptin is reduced with sodium borohydride to leupeptinol, and then converted to a fluorescent derivative with benzoin. The derivative is separated on a reversed-phase column (LiChrosorb RP-18) with isocratic elution and determined with fluorescence detection. The detection limits of leupeptin in serum and muscle are 250 pmol/ml (107 ng/ml) and 500 pmol/g (214 ng/g), respectively, corresponding to approximately 150 fmol each in a 100-microliters injection volume. This method is simple and sensitive enough to permit the quantification of leupeptin in biological samples from mice dosed with leupeptin.

High-performance liquid chromatographic measurement of guanidino compounds of clinical importance in human urine and serum by pre-column fluorescence derivatization using benzoin

High-performance liquid chromatographic microanalyses for guanidino compounds in human physiological fluids have been accomplished by means of a pre-column fluorescence derivatization method using benzoin. The guanidino compounds in urine or deproteinized serum after ultrafiltration are converted to the fluorescent derivatives with benzoin in an alkaline medium, and the derivatives are separated simultaneously within 25 min on a reversed-phase column (mu Bondapak Phenyl) with a linear gradient elution of methanol in aqueous mobile phase (pH 8.5). The method permits the quantitative determination of guanidinosuccinic acid, methylguanidine, taurocyamine and guanidinobutyric acid at concentrations of as low as 8-78 pmol/ml in human urine and serum.

A fluorometric method for the specific determination of serum arginine with 2,3-naphthalenedicarbaldehyde

A specific and simple fluorometric method for the determination of serum arginine was developed which consists of (1) deproteinization of serum sample with 10% perchloric acid, (2) blocking thiol compounds with N-ethylmaleimide, (3) fluorescence reaction with 2,3-naphthalenedicarbaldehyde in 0.2 M borate buffer, pH 9.3, in the presence of beta-cyclodextrin (25 min at 20 degrees C, excitation wavelength: 462 nm, emission wavelength: 520 nm). Since the fluorescence reaction is highly specific for arginine, the method requires no other separation step. Linearity, recovery, and reproducibility of the method were found to be satisfactory.

High-performance liquid chromatographic analyser for guanidino compounds using benzoin as a fluorogenic reagent

An automatic analyser based on high-performance liquid chromatography has been developed for the quantification of biogenic guanidino compounds in human physiological fluids. Fourteen guanidino compounds are mutually separated within 35 min on a cation-exchange column with a stepwise gradient elution of pH and/or ionic strength in the mobile phase and then converted automatically to their fluorescent derivatives with benzoin. The method in this system is simple, rapid and sensitive; the lower limits of detection are 5-50 pmol for monosubstituted guanidino compounds, 1 nmol for creatine and 20 nmol for creatinine in 100 microliter of injection volume.